BackVanda Pharmaceuticals Overview

Vanda Pharmaceuticals Current Cash

Latest current cash for VNDA: $56M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$55.88M
31.00% YoYΔ $-25.10M vs prior year quarter

Peer trimmed avg / median

Loading

Vanda Pharmaceuticals Current Cash History

Loading

Vanda Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Vanda Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vanda Pharmaceuticals (VNDA) FAQ

As of the most recent data (June 2026), VNDA shows a current cash of $56M. That compares with $81M in the prior-year period — down 31.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VNDA's current cash is now $56M (was $81M) — a 31.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vanda Pharmaceuticals is outperforming or lagging.

Tracking VNDA's current cash over time shows whether Vanda Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $56M That compares with $81M in the prior-year period — down 31.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Vanda Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $56M) with ownership activity and broader fundamentals.

Vanda Pharmaceuticals's current cash is $56M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.